Statins Revisited: Applications Beyond Lipid Lowering? Statins Revisited: Applications Beyond Lipid Lowering?
Are we using statins to their full potential? Recent studies suggest a larger role for statins beyond their cholesterol-lowering properties.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2023 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Africa: Statin Lowers Cardio Risk in People Living With HIV, Large Study Finds
[spotlight] HIV increases a person's risk of developing cardiovascular disease (CVD), but there are unanswered questions on how to best manage this elevated risk. One such question is whether using a class of cholesterol-lowering medications called statins could reduce the risk of major adverse cardiovascular events- MACE for short- in people living with HIV who have a low-to-moderate risk of CVD. This question has now been answered in a study published in the New England Journal of Medicine, according to Dr Steven Gr (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 27, 2023 Category: African Health Tags: Africa HIV-Aids and STDs Health and Medicine Science and Biotechnology South Africa Southern Africa Sustainable Development Source Type: news
Minorities, Women Are Shortchanged When It Comes to Statins
WEDNESDAY, July 26, 2023 -- In yet another example of inequities in U.S. health care, new research indicates that many women and minority men who need statins to protect their heart aren ' t getting them. “The recommendation to use statins to treat... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 26, 2023 Category: General Medicine Source Type: news
Statins Post-PCI: Moderate-Intensity and Add Ezetimibe? Statins Post-PCI: Moderate-Intensity and Add Ezetimibe?
The reward for avoiding high-intensity-statin monotherapy could be better safety and clinical outcomes, suggests a registry study that supports randomized evidence.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 25, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
A Statin a Day Keeps Heart Trouble Away for Those With HIV
TUESDAY, July 25, 2023 – Heart disease is a high risk for people with HIV, but a new study finds that taking statins significantly reduces the risk of serious heart incidents.
People with HIV who took a daily statin pill lowered their risk of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 25, 2023 Category: General Medicine Source Type: news
Study Looks at Race-Ethnicity-Gender Disparities in Statin Use
MONDAY, July 24, 2023 -- For several race-ethnicity-gender groups, statin use disparities are not explained by measurable differences in medical appropriateness of therapy, access to health care, or socioeconomic status, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2023 Category: Pharmaceuticals Source Type: news
Statin Reduced Risk of Heart Disease in People With HIV
(MedPage Today) -- BRISBANE, Australia -- The cholesterol-lowering agent pitavastatin (Livalo) as primary prevention reduced the risk of major adverse cardiovascular events (MACE) among people living with HIV, the randomized REPRIEVE trial showed... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 24, 2023 Category: Cardiology Source Type: news
Daily Statin Cuts Cardiovascular Risk in HIV Daily Statin Cuts Cardiovascular Risk in HIV
Final data from the REPRIEVE trial show pitavastatin therapy is associated with a significantly lower risk of cardiovascular events than placebo as evidence grows for statins in primary prevention.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 24, 2023 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Daily statin reduces heart disease risk among adults living with HIV
NIH-funded clinical trial finds cholesterol-lowering treatment reduced cardiovascular events by 35%. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - July 24, 2023 Category: American Health Source Type: news
Statins do not cause early onset cataracts, study suggests
Statin use is not the cause of early onset cataracts, according to a new genetic study of British South East Asians by scientists at St Mary University in London. The study, which challenges previous work linking statin use to increased cataract risk, suggests that individuals with a genetic variant associated with higher statin exposure actually... Read moreThe post Statins do not cause early onset cataracts, study suggests appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - July 13, 2023 Category: Nursing Authors: Carolyn Scott Tags: Cardiology cataracts eye health statins Source Type: news
US FDA Approves Expanded Indication for Novartis Leqvio (inclisiran) to Include Treatment of Adults with High LDL-C and Who Are At Increased Risk of Heart Disease
Expanded indication now enables broader use of Leqvio for LDL-C reduction in patients with primary hyperlipidemia (high LDL-C) 1
Leqvio can now be used earlier in LDL-C treatment as an adjunct to diet and statin therapy for patients who have not... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 10, 2023 Category: Drugs & Pharmacology Source Type: news
US FDA Approves Expanded Indication for Leqvio (inclisiran) to Include Treatment of Adults with High LDL-C and Who Are At Increased Risk of Heart Disease
Expanded indication now enables broader use of Leqvio for LDL-C reduction in patients with primary hyperlipidemia (high LDL-C) 1
Leqvio can now be used earlier in LDL-C treatment as an adjunct to diet and statin therapy for patients who have not... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 10, 2023 Category: Drugs & Pharmacology Source Type: news
FDA OKs Inclisiran, Added to Statins, for Primary Prevention FDA OKs Inclisiran, Added to Statins, for Primary Prevention
The injectable agent ' s indications now include high-risk patients with primary dyslipidemia who are taking statins but who do not have a history of cardiovascular events.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 10, 2023 Category: Cardiology Tags: Cardiology News Alert Source Type: news
NHS faces statins crisis as pharmacies report 'desperate' shortages of life-saving drug
Almost eight million Britons rely on statins to lower their cholesterol levels, which in turn reduce the risk of heart attacks and strokes. Prices of the life-saving drug have rocketed due to the shortages. (Source: the Mail online | Health)
Source: the Mail online | Health - July 10, 2023 Category: Consumer Health News Source Type: news
Is This New Medication Another Solution For High Cholesterol?
Many people don't like taking statins, a common treatment for high cholesterol. New research is now offering another easy option. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - July 6, 2023 Category: Consumer Health News Source Type: news
